Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage.

Slides:

Advertisements

Similar presentations

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis Dr Michael Roerecke, PhD, Prof Janusz Kaczorowski,

Advertisements

Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa Prof Tonya Renee Thurman,

Expanding the global profile of people who inject drugs: Summarising recent reviews Louisa Degenhardt.

Coverage of HIV and HCV prevention interventions for people who inject drugs Dr Sarah Larney, Senior Research Fellow.

The commercial determinants of health

Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study Gabrielle Campbell,

The Ebola suspect's dilemma

Natural environments and suicide mortality in the Netherlands: a cross-sectional, ecological study Marco Helbich, PhD, Derek de Beurs, PhD, Prof Mei-Po.

Assessment of progress towards universal health coverage for people with disabilities in Afghanistan: a multilevel analysis of repeated cross-sectional.

HIV, Anti-HCV And HBsAg in

Mental health indicators associated with oil spill response and clean-up: cross-sectional analysis of the GuLF STUDY cohort Richard K Kwok, PhD, John.

Charity begins at home in global health research funding

Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden.

Threats to human health by great ocean garbage patches

Epidemiological data for hepatitis D in Africa

Prevalence of cerebral palsy in Uganda: a population-based study

Do air quality alerts benefit public health? New evidence from Canada

The impact of surgery on global climate: a carbon footprinting study of operating theatres in three health systems Andrea J MacNeill, MD, Robert Lillywhite,

Gender myths in global health

The prevalence of non-fatal overdose among people who inject drugs

Nicola Low, Joost H Smid The Lancet Public Health

Effective cross-sector collaborations create sustainability

The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis Alexandra Frost, MSc, Prof.

National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis Shannon Lange,

Anthony Rodgers, Alistair Woodward, Boyd Swinburn, William H Dietz

Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis

Sherif M Abdalla, Robert Bortolussi, Noni E MacDonald

The effect of multiple adverse childhood experiences on health: a systematic review and meta-analysis Prof Karen Hughes, PhD, Prof Mark A Bellis, DSc,

Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review

Health consequences of exposure to e-waste: a systematic review

Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label,

Trends in infant mortality in Venezuela between 1985 and 2016: a systematic analysis of demographic data Jenny García, MSc, Prof Gerardo Correa, MSc,

Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.

Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa Prof Tonya Renee Thurman,

Tobacco use and second-hand smoke exposure in young adolescents aged 12–15 years: data from 68 low-income and middle-income countries Prof Bo Xi, PhD,

Volume 393, Issue 10172, Pages (February 2019)

Elder abuse prevalence in community settings: a systematic review and meta-analysis Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,

Sufang Guo, Nuzhat Rafique, Danzhen You, Douglas J Noble

The growth and strategic functioning of One Health networks: a systematic analysis Mishal S Khan, PhD, Peregrine Rothman-Ostrow, MSc, Julia Spencer, MSc,

Forecasting the care needs of the older population in England over the next 20 years: estimates from the Population Ageing and Care Simulation (PACSim)

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis Jack Stone,

Effective interventions for unintentional injuries: a systematic review and mortality impact assessment among the poorest billion Andres I Vecino-Ortiz,

The impact of surgery on global climate: a carbon footprinting study of operating theatres in three health systems Andrea J MacNeill, MD, Robert Lillywhite,

Association of parental supply of alcohol with adolescent drinking, alcohol-related harms, and alcohol use disorder symptoms: a prospective cohort study

Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries:

Epidemiological data for hepatitis D in Africa

Thank you to our diverse (but not diverse enough) reviewers

Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study N Saman Wijesooriya, MPH, Roger W Rochat, MD, Mary.

Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis Archana Asundi, MD, Alina Beliavsky, MD, Xing.

Matthieu J Guitton The Lancet Planetary Health

Implementation of key demand-reduction measures of the WHO Framework Convention on Tobacco Control and change in smoking prevalence in 126 countries:

Spatial lifecourse epidemiology

Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people.

Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review Alexander K Rowe,

How concentrated are academic publications of countries' progression towards universal health coverage? Adrian Gheorghe, Kalipso Chalkidou, Anthony Culyer

Reducing the global burden of preterm births

Health systems' capacity to provide post-abortion care: a multicountry analysis using signal functions Onikepe O Owolabi, PhD, Ann Biddlecom, PhD, Hannah.

Restructuring physical micro-environments to reduce the demand for meat: a systematic review and qualitative comparative analysis Filippo Bianchi, MPhil,

Jean H Humphrey, Andrew J Prendergast The Lancet Global Health

Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 Prof Peter Lloyd-Sherlock,

Population attributable fractions for risk factors for dementia in low-income and middle- income countries: an analysis using cross-sectional survey data

Deriving a practical framework for the evaluation of health apps

Excess under-5 female mortality across India: a spatial analysis using 2011 census data Christophe Z Guilmoto, PhD, Nandita Saikia, PhD, Vandana Tamrakar,

Peng Jia, Youfa Wang The Lancet Global Health

The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis Dr Michael Roerecke, PhD, Prof Janusz Kaczorowski,

The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions Katherine E.

Economic decline, incarceration, and mortality from drug use disorders in the USA between 1983 and 2014: an observational analysis Elias Nosrati, PhD,

Correction to Lancet Gastroenterol Hepatol 2018; 4: 435–44

Institutional challenges to achieving health equity in Ecuador

Sickle cell disease: a new era

Presentation transcript:

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review Prof Louisa Degenhardt, PhD, Amy Peacock, PhD, Samantha Colledge, BPsychSc[Hons], Janni Leung, PhD, Jason Grebely, PhD, Prof Peter Vickerman, PhD, Jack Stone, MMathStat, Evan B Cunningham, BSc[Hons], Adam Trickey, MSc, Kostyantyn Dumchev, MD, Prof Michael Lynskey, PhD, Paul Griffiths, MSc, Prof Richard P Mattick, PhD, Prof Matthew Hickman, PhD, Sarah Larney, PhD The Lancet Global Health Volume 5, Issue 12, Pages e1192-e1207 (December 2017) DOI: 10.1016/S2214-109X(17)30375-3 Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

Figure 1 Flowchart presenting number of sources from identification to inclusion UNODC WDR=UN Office on Drugs and Crime's World Drug Report. GSHR=HRI's Global State of Harm Reduction. EMCDDA=European Monitoring Centre on Drugs and Drug Addiction. HBV=hepatitis B virus. HCV=hepatitis C virus. IDU=injecting drug use. The Lancet Global Health 2017 5, e1192-e1207DOI: (10.1016/S2214-109X(17)30375-3) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

Figure 2 Estimated prevalence of injecting drug use by country IDU=injecting drug use. The Lancet Global Health 2017 5, e1192-e1207DOI: (10.1016/S2214-109X(17)30375-3) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

Figure 3 Estimated HIV prevalence among people who inject drugs by country IDU=injecting drug use. No eligible report=evidence of IDU located, but no study of HIV prevalence among people who inject drugs that met our eligibility criteria was located. The Lancet Global Health 2017 5, e1192-e1207DOI: (10.1016/S2214-109X(17)30375-3) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

Figure 4 Estimated anti-hepatitis C virus prevalence among people who inject drugs by country IDU=injecting drug use. No eligible report=evidence of IDU located, but no study of HCV antibody prevalence among people who inject drugs that met our eligibility criteria was located. The Lancet Global Health 2017 5, e1192-e1207DOI: (10.1016/S2214-109X(17)30375-3) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions

Figure 5 Estimated hepatitis B virus surface antigen prevalence among people who inject drugs by country IDU=injecting drug use. No eligible report=evidence of IDU located, but no study of hepatitis B surface antigen prevalence among people who inject drugs that met our eligibility criteria was located. The Lancet Global Health 2017 5, e1192-e1207DOI: (10.1016/S2214-109X(17)30375-3) Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Terms and Conditions